Status:
COMPLETED
The Effects on Growth and Tolerance of an Infant Formula Fed to Term Infants
Lead Sponsor:
Mead Johnson Nutrition
Conditions:
Growth of Term Infants
Eligibility:
All Genders
12-16 years
Phase:
NA
Brief Summary
This clinical trial will evaluate an investigational infant formula with a probiotic to determine if it provides normal growth and if it is well tolerated by term infants compared to a marketed routin...
Eligibility Criteria
Inclusion
- Singleton, 12-16 days of age at randomization
- Term infant with birth weight of a minimum of 2500 grams
- Solely formula fed
- Signed Informed Consent and Protected Health Information
Exclusion
- History of underlying metabolic or chronic disease or immunocompromised
- Feeding difficulties or formula intolerance
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
348 Patients enrolled
Trial Details
Trial ID
NCT01897922
Start Date
July 1 2013
End Date
April 1 2014
Last Update
September 25 2015
Active Locations (22)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham Pediatric Associates
Birmingham, Alabama, United States, 35205
2
Greenvale Pediatrics Hoover
Birmingham, Alabama, United States, 35244
3
Southeastern Pediatric Associates
Dothan, Alabama, United States, 36305
4
Pediatrics East - Alabama Clinical Therapeutics
Pinson, Alabama, United States, 35126